Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of September 11, 2026, ZLAB trades at $24.17 with a market cap of $2.82B and a P/E ratio of -143.65. ZLAB moved -0.00% today. Year to date, ZLAB is +39.47%; over the trailing twelve months it is -14.89%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $39.33. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ZLAB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $24.17 |
| Market Cap | $2.82B |
| P/E Ratio | -143.65 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.34 |
| 52-Week Low | $15.96 |
| Volume | 143.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $449.61M |
| Net Income | $-188.21M |
| Gross Margin | 56.51% |
3 analysts cover ZLAB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.33.